MELI vs QNRX · P/E 43, rev $19.01B vs $9.6M cap
MercadoLibre Inc. (MELI) versus Quoin Pharmaceuticals Ltd DRC (QNRX) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
QNRX does not have a complete income-statement cache yet.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. QNRX currently screens at market cap $9.6M.
Not investment advice. Open the MELI and QNRX stock pages for the full models.
Not investment advice.